These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2731185)

  • 1. Serological response of non-human primates to human melanoma disialoganglioside GD3.
    Stuhlmiller GM; Roberson KM; Seigler HF
    Cancer Immunol Immunother; 1989; 29(3):205-10. PubMed ID: 2731185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of melanoma-associated gangliosides in cancer patients.
    Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
    Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse.
    Livingston PO; Ritter G; Calves MJ
    Cancer Immunol Immunother; 1989; 29(3):179-84. PubMed ID: 2731184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH; Morton DL; Irie RF
    Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very low density lipoproteins and interleukin 2 enhance the immunogenicity of 9-O-acetyl-GD3 ganglioside in BALB/c mice.
    Dumontet C; Rebbaa A; Portoukalian J
    J Immunol Methods; 1997 Aug; 206(1-2):115-23. PubMed ID: 9328574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
    Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
    Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
    Pukel CS; Lloyd KO; Travassos LR; Dippold WG; Oettgen HF; Old LJ
    J Exp Med; 1982 Apr; 155(4):1133-47. PubMed ID: 7061953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen.
    Stuhlmiller GM; Darrow TL; Haupt DM; Seigler HF
    Cancer Immunol Immunother; 1987; 25(3):193-200. PubMed ID: 3677123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response to disialoganglioside GD3 vaccination in normal dogs: a melanoma surface antigen vaccine.
    Milner RJ; Salute M; Crawford C; Abbot JR; Farese J
    Vet Immunol Immunopathol; 2006 Dec; 114(3-4):273-84. PubMed ID: 17027091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.
    Helling F; Shang A; Calves M; Zhang S; Ren S; Yu RK; Oettgen HF; Livingston PO
    Cancer Res; 1994 Jan; 54(1):197-203. PubMed ID: 8261439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of antibodies against GD3 ganglioside in melanoma patients by vaccination with GD3-lactone-KLH conjugate plus immunological adjuvant QS-21.
    Ragupathi G; Meyers M; Adluri S; Howard L; Musselli C; Livingston PO
    Int J Cancer; 2000 Mar; 85(5):659-66. PubMed ID: 10699946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3.
    Ren S; Ariga T; Scarsdale JN; Zhang Y; Slominski A; Livingston PO; Ritter G; Kushi Y; Yu RK
    J Lipid Res; 1993 Sep; 34(9):1565-72. PubMed ID: 8228639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3.
    Ohta S; Honda A; Tokutake Y; Yoshida H; Hanai N
    Cancer Immunol Immunother; 1993; 36(4):260-6. PubMed ID: 8439988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific serological response by active immunization with GD3-bearing liposomes.
    Massó O; Aliño SF; Lejarreta M; Blasco F; Piulats J
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1114-20. PubMed ID: 8819493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution study of murine monoclonal anti-GD3 antibody in nude mice bearing human melanoma xenografts for development of immunoscintigraphy.
    Ojima F; Ido T; Kijima-Suda I; Nakagawa Y
    Tohoku J Exp Med; 1998 Jun; 185(2):89-100. PubMed ID: 9747648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.
    Cheresh DA; Honsik CJ; Staffileno LK; Jung G; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5155-9. PubMed ID: 3860849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
    Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
    Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin.
    Ravindranaths MH; Paulson JC; Irie RF
    J Biol Chem; 1988 Feb; 263(4):2079-86. PubMed ID: 3339003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
    Livingston PO; Natoli EJ; Calves MJ; Stockert E; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2911-5. PubMed ID: 3472242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface reactive human monoclonal antibody directed to human melanoma-associated gangliosides.
    Abdel-Wahab Z; Li WP; Darrow T; Nudelman ED; Towell A; Seigler HF
    Melanoma Res; 1993 Dec; 3(6):415-23. PubMed ID: 8161881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.